课题基金 / 基金详情

Molecular Signalling Pathways and Cellular Stress in Diabetic Embryopathy

Molecular Signalling Pathways and Cellular Stress in Diabetic Embryopathy
糖尿病胚胎病的分子信号通路和细胞应激
批准号:
8767371
负责人:
E. Albert Reece
金额:
$42.92万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-06-01 至 2018-05-31

项目摘要

项目成果

E. Albert Reece的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):糖尿病妇女所生婴儿中有高达10%会发生先天性畸形。最优的血糖控制很难实现和维持,即使是短暂的高血糖暴露也会导致畸形。目前的建议是基于我们关于PKC通路的发现,PKC通路与糖尿病胚胎病变的诱导密切相关。由于PKC激活下游的分子中间产物尚未确定,我们提出了一个新的假设,即母体高血糖诱导的PKCA/d激活通过DNA高甲基化降低SIRT2的表达。SIRT2的下调阻止了持续的抗氧化酶的表达,并诱导了Marcks的过度乙酰化,从而促进了Marcks的磷酸化。发育中的神经管中依赖PKC的SIRT2下调和Marcks的磷酸化是导致神经上皮细胞凋亡和NTD形成的细胞应激的原因。目的1研究PKCA和PKCd是否通过DNA高甲基化抑制糖尿病胚胎病变中SIRT2的表达。我们假设PKCA和PKCd增加了从头DNA甲基转移酶(DNMT3A/B)的表达,从而诱导SIRT2启动子的高甲基化并抑制其表达。目的2研究SIRT2在糖尿病胚胎病变中PKC诱导的细胞应激、MARCKS磷酸化和NTD形成中的作用。我们的工作假设是,SIRT2的下调降低了抗氧化酶的表达,从而导致氧化和内质网应激,并导致Marcks乙酰化和磷酸化增加,从而导致细胞应激。目的3将确定Marcks磷酸化在糖尿病诱导的细胞应激、细胞凋亡和NTD形成中的因果作用。我们将验证依赖于PKCA/d的Marcks磷酸化诱导细胞应激和线粒体功能障碍,导致细胞凋亡和NTD形成的假设。该项目的成功将极大地填补目前关于导致糖尿病胚胎病变的事件的知识库的空白。
英文摘要
DESCRIPTION (provided by applicant): Congenital malformations occur in up to 10% of babies born to diabetic women. Optimal glycemic control is difficult to achieve and maintain, and even transient exposure to hyperglycemia can cause malformations. This current proposal is formulated on the basis of our findings relative to the PKC pathway, which is critically involved i the induction of diabetic embryopathy. Because the molecular intermediates downstream PKC activation have not been determined, we have advanced a novel hypothesis that maternal hyperglycemia-induced PKCa/d activation reduces the expression of SIRT2 through DNA hypermethylation. SIRT2 downregulation prevents sustainable antioxidant enzyme expression and induces MARCKS hyperacetylation, which contributes to MARCKS phosphorylation. PKC-dependent SIRT2 downregulation and MARCKS phosphorylation in the developing neural tube are responsible for cellular stresses that cause neuroepithelial cell apoptosis and NTD formation. Aim 1 will determine whether PKCa and PKCd suppress SIRT2 expression through DNA hypermethylation in diabetic embryopathy. We hypothesize that that PKCa and PKCd increases the expression of de novo DNA methyltransferases (DNMT3A/B), which induce hypermethylation in the SIRT2 promoter and inhibit its expression. Aim 2 will determine the role of SIRT2 in PKC-induced cellular stress, MARCKS phosphorylation and NTD formation in diabetic embryopathy. Our working hypothesis is that downregulation of SIRT2 decreases antioxidant enzyme expression, which results in oxidative and endoplasmic reticulum stress, and leads to an increase in MARCKS acetylation and phosphorylation, which contributes to cellular stress. Aim 3 will determine the causal role of MARCKS phosphorylation in diabetes-induced cellular stress, apoptosis and NTD formation. We will test the hypothesis that PKCa/d-dependent MARCKS phosphorylation induces cellular stress and mitochondrial dysfunction, resulting in apoptosis and NTD formation. The success of this project will significantly fill the gaps in the current knowledge base regarding events that cause diabetic embryopathy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Epitranscriptomic Alteration and Planar Cell Polarity Signaling In Diabetic Embroyopathy
  • 批准号:
    10267759
  • 项目类别:
  • 资助金额:
    $57.52万
  • 财政年份:
    2020
  • 负责人:
    E. Albert Reece
  • 依托单位:
Epitranscriptomic Alteration and Planar Cell Polarity Signaling In Diabetic Embroyopathy
  • 批准号:
    10453652
  • 项目类别:
  • 资助金额:
    $57.52万
  • 财政年份:
    2020
  • 负责人:
    E. Albert Reece
  • 依托单位:
Epitranscriptomic Alteration and Planar Cell Polarity Signaling In Diabetic Embroyopathy
  • 批准号:
    10676158
  • 项目类别:
  • 资助金额:
    $57.52万
  • 财政年份:
    2020
  • 负责人:
    E. Albert Reece
  • 依托单位:
Epitranscriptomic Alteration and Planar Cell Polarity Signaling In Diabetic Embroyopathy
  • 批准号:
    10116005
  • 项目类别:
  • 资助金额:
    $58.69万
  • 财政年份:
    2020
  • 负责人:
    E. Albert Reece
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: